Label: LAXATIVE- docusate sodium and sennosides capsule, liquid filled

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 8, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

  • Active Ingredient (in each Softgel)

    Docusate sodium 50 mg

    Sennosides 8.6 mg

  • Purpose

    Stool softener

    Laxative

  • Uses

    • relieves occasional constipation (irregularity) • generally produces bowel movement in 6–12 hours

  • Warnings

    Do not use • if you are now taking mineral oil, unless directed by a doctor • laxative products for longer than 1 week, unless directed by a doctor

    Ask a doctor before use if you have • stomach pain • nausea • vomiting • noticed a sudden change in bowel habits that continues over a period of 2 weeks

    Ask a doctor or pharmacist before use if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

    Stop use and ask a doctor if • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition • you need to use a stool softener
    laxative for more than 1 week

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

  • Directions

    take preferably at bedtime or as directed by a doctor

    Age Starting Dosage Maximum Dosage
    adults & children 12 years of age & over 2 tablets once a day 4 tablets twice a day 
    children 6 to under 12 years of age 1 tablet once a day 2 tablets twice a day 
    children 2 to under 6 years ½ tablet once a day 1 tablet twice a day 
    children under 2 years ask a doctor ask a doctor 

  • Other information

    • each tablet contains: calcium 2 mg and sodium 6 mg
    • store at 25°C (77°F); excursions permitted between 15°–30°C (59°–86°F)

  • Inactive ingredients

    Light liquid paraffin, Soya lecithin, Beeswax, Colloidal silicon dioxide (aerosol), Sodium Carboxymethyl Cellulose, titanium dioxide, Gelatin, Glycerin, Sorbitol sorbitan, Povidone, FD&C Yellow-6, FD&C Red-33, spl, Purified water

  • Questions or comments?

    1-888-333-9792

  • SPL UNCLASSIFIED SECTION

    Distributed by:
    RITE AID
    30 Hunter Lane, Camp Hill, PA 17011

    www.riteaid.com

    Made in India

  • Label

    Laxative label

    Carton

    Laxative carton

  • INGREDIENTS AND APPEARANCE
    LAXATIVE 
    docusate sodium and sennosides capsule, liquid filled
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11822-1572
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    PARAFFIN (UNII: I9O0E3H2ZE)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    SYNTHETIC BEESWAX (UNII: 08MNR5YE2R)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    GELATIN (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    NONCRYSTALLIZING SORBITOL SOLUTION (UNII: 9E0S3UM200)  
    POVIDONE K30 (UNII: U725QWY32X)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    WATER (UNII: 059QF0KO0R)  
    Product Characteristics
    ColorredScoreno score
    ShapeOVALSize10mm
    FlavorImprint Code 584
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11822-1572-61 in 1 CARTON12/27/2021
    160 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00712/27/2021
    Labeler - RITE AID CORPORATION (014578892)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!